Perioperative Antiplatelet therapy in patients with drug-eluting Stent undergoing noncardiac SURgEry

Asan Medical Center0 个研究点目标入组 1,000 人开始时间: 待定最近更新: 2024年3月4日

试验速览

暂无简介。

•1.Subject was ? 19 years of age.
•2Patients who successfully implanted at least one or more coronary drug-eluting stents
•3.Patients scheduled for surgery at 12 months after stenting.
•4.Patients scheduled for elective non-cardiac surgery
•5.The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethical Committee of the respective clinical site.

•1.Patient who currently have a symptom of acute coronary syndrome or myocardial infarction within 1 month
•2.Patient who have dyspnea on exertion(NYHA Fc III~IV) due to severe left ventricular dysfunction(EF=30%) or severe valvular heart disease
•3.Patient who have Intolerance for aspirin
•4.Patient who need for anticoagulation therapy
•5.Emergent operation
•6Cardiac surgery
•7Very high bleeding risk(ex, Intra-cranial surgery, Intra-spinal surgery, Retinal surgery)
•8Patient who have significantly abnormal findings which identified violation for safety by investigator on physical examination, blood test and electrocardiogram.
•9Concurrent medical condition with a life expectancy of less than 1 years
•10Pregnant and/or lactating women
•11Patient was unable to provide written informed consent or participate in log-term follow up

发起方